Skip to main content
. 2022 Jul 22;13:928742. doi: 10.3389/fimmu.2022.928742

Figure 5.

Figure 5

Kaplan–Meier curves in the TCGA test cohort (A) and the GEO validation cohort (C). TCGA test cohort (B) and GEO validation cohort (C) time-dependent receiver operating characteristic curves for the sensitivity and specificity of the prognosis assessment (D). Gene set variation analysis of the GEO validation cohort (the unit of color bars is log2 (actual expression) +1) (E). In the TCGA dataset, principal component analysis was used to evaluate the distribution patterns of the high- and low-risk patients (F). Prognostic signature decision curve analysis at 1 (G), 3 (H), and 5 years (I). Gene set variation analysis of the entire TCGA cohort (the unit of color bars is log2 (actual expression) +1) (J) (* p < 0.05, ** p < 0.01, *** p < 0.001).